发明名称 |
CD37 IMMUNOTHERAPEUTIC AND COMBINATION WITH BIFUNCTIONAL CHEMOTHERAPEUTIC THEREOF |
摘要 |
The present disclosure provides a humanized anti-CD37 small modular immunopharmaceutical (SMIP) molecule, as well as synergistic combination therapies of CD37-specific binding molecules (such as anti-CD37 SMIP proteins or antibodies) with bifunctional chemotherapeutics (such as bendamustine) that can be administered concurrently or sequentially, for use in treating or preventing B-cell related autoimmune, inflammatory, or hyperproliferative diseases. |
申请公布号 |
KR20110013391(A) |
申请公布日期 |
2011.02.09 |
申请号 |
KR20107025224 |
申请日期 |
2009.04.11 |
申请人 |
EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC |
发明人 |
TAN PHILIP;SIMON SANDY ALEXANDER;CERVENY CHARLES G.;NILSSON CHRISTY ANNE;BRADY WILLIAM;LEDBETTER JEFFREY A.;HAYDEN LEDBETTER MARTHA SUSAN;THOMPSON PETER ARMSTRONG;MORALES CECILE |
分类号 |
C07K16/28;A61K39/395;A61P35/02;C12N15/13 |
主分类号 |
C07K16/28 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|